JP2011526887A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011526887A5 JP2011526887A5 JP2011516261A JP2011516261A JP2011526887A5 JP 2011526887 A5 JP2011526887 A5 JP 2011526887A5 JP 2011516261 A JP2011516261 A JP 2011516261A JP 2011516261 A JP2011516261 A JP 2011516261A JP 2011526887 A5 JP2011526887 A5 JP 2011526887A5
- Authority
- JP
- Japan
- Prior art keywords
- infection
- composition
- caused
- resistant
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- HPWUWKIHYFPDGW-LBPRGKRZSA-N COc(c(N(C[C@H](C1)N)CC1=C)ccc12)c1N(C1CC1)C=C(C(O)=O)C2=O Chemical compound COc(c(N(C[C@H](C1)N)CC1=C)ccc12)c1N(C1CC1)C=C(C(O)=O)C2=O HPWUWKIHYFPDGW-LBPRGKRZSA-N 0.000 description 2
- AVPQPGFLVZTJOR-UHFFFAOYSA-N CC(CC(C1)N)CN1c(c(OC)c1N(C2CC2)C=C2C(O)=O)ccc1C2=O Chemical compound CC(CC(C1)N)CN1c(c(OC)c1N(C2CC2)C=C2C(O)=O)ccc1C2=O AVPQPGFLVZTJOR-UHFFFAOYSA-N 0.000 description 1
- JUJVJGOLGIJVHU-UHFFFAOYSA-N COc(c(N1CC2(CC2)CCC1)ccc12)c1N(C1CC1)C=C(C(O)=O)C2=O Chemical compound COc(c(N1CC2(CC2)CCC1)ccc12)c1N(C1CC1)C=C(C(O)=O)C2=O JUJVJGOLGIJVHU-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7729308P | 2008-07-01 | 2008-07-01 | |
| US61/077,293 | 2008-07-01 | ||
| PCT/US2008/075549 WO2010002415A1 (en) | 2008-07-01 | 2008-09-08 | Treatment of antibiotic-resistant bacteria infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011526887A JP2011526887A (ja) | 2011-10-20 |
| JP2011526887A5 true JP2011526887A5 (enExample) | 2011-12-01 |
Family
ID=41464848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011516261A Pending JP2011526887A (ja) | 2008-07-01 | 2008-09-08 | 抗生物質耐性菌感染症の治療 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8211909B2 (enExample) |
| EP (1) | EP2303271B1 (enExample) |
| JP (1) | JP2011526887A (enExample) |
| KR (2) | KR20150006080A (enExample) |
| CN (1) | CN101618038B (enExample) |
| AU (1) | AU2008358909B2 (enExample) |
| CA (1) | CA2728328C (enExample) |
| EA (1) | EA018653B1 (enExample) |
| NZ (1) | NZ588898A (enExample) |
| TR (1) | TR201820964T4 (enExample) |
| TW (1) | TWI375558B (enExample) |
| WO (1) | WO2010002415A1 (enExample) |
| ZA (1) | ZA201100616B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101392808B1 (ko) * | 2011-12-30 | 2014-05-12 | 순천대학교 산학협력단 | 식물 추출물 또는 이의 분획물을 포함하는 항균용 조성물 |
| CN103145615B (zh) * | 2013-03-20 | 2015-07-29 | 浙江医药股份有限公司 | 一种奈诺沙星螯合物的后处理方法 |
| KR101392810B1 (ko) * | 2013-09-25 | 2014-05-12 | 순천대학교 산학협력단 | 된장풀 추출물 또는 이의 분획물을 포함하는 항균용 조성물 |
| US9492374B2 (en) | 2015-03-25 | 2016-11-15 | Jose Rafael Salinas Andrade | Composition and method for treatment of ulcers |
| CN105368825B (zh) * | 2015-10-14 | 2019-09-10 | 华东医院 | 幽门螺杆菌抗生素耐药性分析试剂盒及耐药性检测方法 |
| US12358902B2 (en) * | 2017-12-11 | 2025-07-15 | Denovamed Inc. | 5-(2,5-bis(4-chloro-2-isopropylphenyl)thiophen-3-yl)-1H-tetrazole for the topical treatment of bacterial infections |
| CN111979292B (zh) * | 2020-07-27 | 2022-08-05 | 广东省微生物研究所（广东省微生物分析检测中心） | 一种同时携带多重耐药基因cfr和lsa(E)的MRSA的用途 |
| CN114437026A (zh) * | 2021-10-26 | 2022-05-06 | 浙江医药股份有限公司新昌制药厂 | 一种低组合物杂质的苹果酸奈诺沙星原料药及其制备方法 |
| CN118852222B (zh) * | 2024-06-27 | 2025-09-05 | 南京桦冠生物技术有限公司 | 一种奈诺沙星中间体及其制备方法和应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US100800A (en) | 1870-03-15 | Improvement in riding attachments for plows | ||
| US3989816A (en) | 1975-06-19 | 1976-11-02 | Nelson Research & Development Company | Vehicle composition containing 1-substituted azacycloheptan-2-ones |
| US4444762A (en) | 1980-04-04 | 1984-04-24 | Nelson Research & Development Company | Vehicle composition containing 1-substituted azacyclopentan-2-ones |
| EP1015445B1 (en) | 1997-09-15 | 2009-02-25 | The Procter & Gamble Company | Antimicrobial quinolones, their compositions and uses |
| US6387928B1 (en) * | 1997-09-15 | 2002-05-14 | The Procter & Gamble Co. | Antimicrobial quinolones, their compositions and uses |
| US6348624B1 (en) | 1998-01-09 | 2002-02-19 | The Procter & Gamble Co. | Process for making certain benzoic acid compounds |
| DK1343766T3 (da) | 2000-12-14 | 2005-10-31 | Procter & Gamble | Procestrin med cyklisering ved fremstilling af quinoloner og naphthyridiner |
| US6900224B2 (en) * | 2002-07-31 | 2005-05-31 | The Procter & Gamble Company | Antimicrobial quinolones, their compositions and uses |
| US6803469B2 (en) | 2002-08-05 | 2004-10-12 | The Procter & Gamble Company | Process for preparing quinolone antibiotic intermediates |
| WO2005026145A2 (en) * | 2003-09-12 | 2005-03-24 | Warner-Lambert Company Llc | Quinolone antibacterial agents |
| DK2001862T3 (da) | 2006-03-28 | 2011-08-08 | Warner Chilcott Co Llc | Malatsalte og polymorfe af (3S,5S)-7-[3-amino-5-methyl-piperidinyl]-1-cyklopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolincarboxylsyre |
| JP4876165B2 (ja) | 2006-03-28 | 2012-02-15 | ザ プロクター アンド ギャンブル カンパニー | キノロン中間体を調製するための水素化物還元法 |
| BRPI0709220A2 (pt) * | 2006-03-28 | 2011-07-12 | Procter & Gamble | processo de acoplamento para preparo de intermediários de quinolona |
| US8658183B2 (en) | 2007-08-09 | 2014-02-25 | Taigen Biotechnology Company, Ltd. | Antimicrobial parenteral formulation |
| US20120157492A1 (en) | 2008-07-15 | 2012-06-21 | Taigen Biotechnology Co., Ltd. | Antibiotic drug |
-
2008
- 2008-09-08 WO PCT/US2008/075549 patent/WO2010002415A1/en not_active Ceased
- 2008-09-08 US US12/206,060 patent/US8211909B2/en active Active
- 2008-09-08 CA CA2728328A patent/CA2728328C/en active Active
- 2008-09-08 AU AU2008358909A patent/AU2008358909B2/en active Active
- 2008-09-08 EP EP08821583.5A patent/EP2303271B1/en active Active
- 2008-09-08 NZ NZ588898A patent/NZ588898A/xx unknown
- 2008-09-08 TR TR2018/20964T patent/TR201820964T4/tr unknown
- 2008-09-08 KR KR1020147036073A patent/KR20150006080A/ko not_active Ceased
- 2008-09-08 EA EA201170121A patent/EA018653B1/ru unknown
- 2008-09-08 KR KR1020107025547A patent/KR20110044168A/ko not_active Ceased
- 2008-09-08 JP JP2011516261A patent/JP2011526887A/ja active Pending
- 2008-09-09 TW TW097134583A patent/TWI375558B/zh active
- 2008-09-26 CN CN2008101700068A patent/CN101618038B/zh active Active
-
2011
- 2011-01-25 ZA ZA2011/00616A patent/ZA201100616B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011526887A5 (enExample) | ||
| Munita et al. | Enterococcal endocarditis: can we win the war? | |
| JP2012513467A5 (enExample) | ||
| WO2007148919A8 (en) | Bacteriophage having killing activity specific to staphylococcus aureus | |
| JP2013519675A5 (enExample) | ||
| WO2008116813A3 (en) | Combination medicaments for treating bacterial infections | |
| CL2008003326A1 (es) | Compuestos derivados de [(2r)-3-[2-(5-fluoro-4-pirimidinil)hidrazino]-3-oxopropil]hidroxiformamida, formas polimorficas 1, 2 y 3 de dichos compuestos; composicion farmaceutica; y su uso en el tratamiento de una enfermedad bacteriana del oido, sinusitis, infeccion del tracto respiratorio superior, entre otras. | |
| JP2012506870A5 (enExample) | ||
| JP2020097577A5 (enExample) | ||
| FI3006038T3 (fi) | Oritavansiinin yksittäisannokset bakteeri-infektion hoitoon tai ehkäisyyn | |
| RU2011130278A (ru) | Новые противобактериальные средства для лечения грамположительных инфекций | |
| JP2012501349A5 (enExample) | ||
| EP3441467A3 (en) | Biotin complexes for treatment and diagnosis of alzheimer's disease | |
| JP2015516419A5 (enExample) | ||
| JP2010500284A5 (enExample) | ||
| JP2011528354A5 (enExample) | ||
| JP2008520660A5 (enExample) | ||
| JP2011515406A5 (enExample) | ||
| JP2024009968A5 (enExample) | ||
| JP2019534289A5 (enExample) | ||
| EP2143436A4 (en) | PROTEIN PRODUCT FOR THE TREATMENT OF INFECTIOUS DISEASES AND CORRESPONDING INFLAMMATION PROCESSES | |
| Davison et al. | C-2 derivatized 8-sulfonamidoquinolines as antibacterial compounds | |
| JP2009503021A5 (enExample) | ||
| JP2008543964A5 (enExample) | ||
| WO2009124086A3 (en) | Antibacterial drug for treatment of staphylococcus aureus and other gram-positive bacterial infections |